{"id":101419,"date":"2025-12-09T21:30:13","date_gmt":"2025-12-09T21:30:13","guid":{"rendered":"https:\/\/www.europesays.com\/se\/101419\/"},"modified":"2025-12-09T21:30:13","modified_gmt":"2025-12-09T21:30:13","slug":"novo-nordisk-slutfor-forvarvet-av-akero-therapeutics","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/101419\/","title":{"rendered":"Novo Nordisk slutf\u00f6r f\u00f6rv\u00e4rvet av Akero Therapeutics"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Danska l\u00e4kemedelsbolaget Novo Nordisk har nu slutf\u00f6rt f\u00f6rv\u00e4rvet av Akero Therapeutics, en aff\u00e4r som presenterades i oktober. Det framg\u00e5r av ett pressmeddelande.\n <\/p>\n<p>K\u00f6peskillingen uppgick till 54 dollar per aktie kontant, eller ett sammanlagt v\u00e4rde om 4,7 miljarder dollar. Aktie\u00e4gare i Akero kommer dessutom att erh\u00e5lla en icke-\u00f6verl\u00e5tbar CVR som ger innehavare r\u00e4tt till en potentiell ytterligare betalning p\u00e5 6 dollar per aktie kontant efter godk\u00e4nnande av EFX f\u00f6r behandling av kompenserad cirros p\u00e5 grund av MASH.\n <\/p>\n<p>Akero har varit noterat p\u00e5 Nasdaq i USA och kommer nu avnoteras.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Stefan Linn\u00e9r<br \/>\n <br class=\"col-start-2\"\/><br \/>\n stefan.linner@finwire.se<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Danska l\u00e4kemedelsbolaget Novo Nordisk har nu slutf\u00f6rt f\u00f6rv\u00e4rvet av Akero Therapeutics, en aff\u00e4r som presenterades i oktober. Det&hellip;\n","protected":false},"author":2,"featured_media":77249,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,34,31,33,32,30],"class_list":{"0":"post-101419","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115691744393712639","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/101419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=101419"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/101419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/77249"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=101419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=101419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=101419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}